Ignite Creation Date:
2024-05-06 @ 11:28 AM
Last Modification Date:
2024-10-26 @ 12:45 PM
Study NCT ID:
NCT03527147
Status:
COMPLETED
Last Update Posted:
2022-08-15
First Post:
2018-04-24
Brief Title:
Platform Study for the Treatment of Relapsed or Refractory Aggressive Non-Hodgkins Lymphoma PRISM Study
Sponsor:
Acerta Pharma BV
Organization:
Acerta Pharma BV
Organization Data
Organization:
Acerta Pharma BV
Class:
INDUSTRY
Study ID:
ACE-LY-111
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Acerta Pharma BV
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| AstraZeneca | INDUSTRY |